SmartHeart®️ is an ECG technology developed by SHL Telemedicine, the leader in home-based medical technology. With SmartHeart®️, users can perform a full mobile ECG in any setting, including the patient’s home, using any mobile device, including smartphones and tablets.
This FDA-cleared technology meets all industry security and privacy standards, making this a safe and reliable platform for providers and patients. The ability to send a 12-lead ECG to the patient, versus sending the patient to the ECG will not only increase access to care, but will provide the opportunity for the medical provider to make a quicker diagnosis.
Contact us to learn more about how SHL continues to develop technology solutions and advanced telemedicine services for monitoring of the heart.